LPL Financial
LAB icon

LPL Financial’s Standard BioTools LAB Stock Holding History

LPL Financial’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Sell
11,138
-2,589
-19% -$3.13K ﹤0.01% 5926
2025
Q4 		$17.6K Sell
13,727
-4,160
-23% -$5.59K ﹤0.01% 5817
2025
Q3 		$23.3K Buy
17,887
+33
+0.2% +$43 ﹤0.01% 5728
2025
Q2 		$21.4K Buy
+17,854
New +$19.8K ﹤0.01% 5465

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

LPL Financial's LAB Position: Q1 2026 in Review

LPL Financial reduced its Standard BioTools (LAB) stake by 19% in Q1 2026, selling an estimated $3.13K and leaving 11,138 shares worth $10.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5926.

LPL Financial first reported a position in LAB in Q2 2025 and has held it in 4 quarters since. The position peaked at $23.3K in Q3 2025. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • LPL Financial held 11,138 shares of Standard BioTools worth $10.2K as of Q1 2026.
  • LPL Financial sold 2,589 Standard BioTools shares in Q1 2026, an estimated $3.13K.
  • Standard BioTools made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5926 holding.
  • LPL Financial first reported a position in Standard BioTools in Q2 2025 and has held it in 4 quarters since.
  • LPL Financial's Standard BioTools position peaked at $23.3K in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.